Literature DB >> 17085108

Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.

Mark E Snyder1, Ariadne Bach, Michael W Kattan, Ganesh V Raj, Victor E Reuter, Paul Russo.   

Abstract

PURPOSE: We determined the incidence of benign renal lesions in patients undergoing definitive surgery for localized renal masses 7 cm or less in maximum radiological diameter, and assessed preoperative and clinical parameters associated with benign histology.
MATERIALS AND METHODS: The records of 1,184 patients who underwent consecutive partial or radical nephrectomies between January 2000 and January 2005 were retrospectively reviewed. We excluded 208 patients with lesions more than 7 cm in maximum radiological diameter, 17 with evidence of renal vein or vena caval invasion, 75 with suspected or documented metastatic disease, 28 with a history of renal cell carcinoma and 41 with no available imaging. Logistic regression was done to determine clinical factors associated with benign renal masses, including radiological tumor size, cystic vs solid appearance, patient sex, age, presenting symptoms and race.
RESULTS: Of 815 nephrectomies in our data set 134 (16.4%) were associated with benign lesions, including oncocytoma in 87 (10.7%), angiomyolipoma in 17 (2%), simple cysts in 10 (1.2%), metanephric adenoma in 8 (1%), cystic nephroma in 5 (0.6%) and other in 7. On multivariate logistic regression analysis only sex was significantly associated with benign histology with females having an OR of 1.8 (95% CI 1.2 to 2.6, p = 0.002). Tumor size was not independently associated with benign histology (p = 0.13).
CONCLUSIONS: A significant number (16.4%) of benign lesions less than 7 cm in radiological diameter were operated on based on suspicious preoperative imaging. Women had almost twice the likelihood of having a benign lesion.

Entities:  

Mesh:

Year:  2006        PMID: 17085108     DOI: 10.1016/j.juro.2006.08.013

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  35 in total

1.  BRAF mutations in metanephric adenoma of the kidney.

Authors:  Toni K Choueiri; John Cheville; Emanuele Palescandolo; André P Fay; Philip W Kantoff; Michael B Atkins; Jesse K McKenney; Victoria Brown; Megan E Lampron; Ming Zhou; Michelle S Hirsch; Sabina Signoretti
Journal:  Eur Urol       Date:  2012-06-09       Impact factor: 20.096

2.  Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size.

Authors:  Brian R Winters; John L Gore; Sarah K Holt; Jonathan D Harper; Daniel W Lin; Jonathan L Wright
Journal:  Urol Oncol       Date:  2015-08-28       Impact factor: 3.498

3.  Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.

Authors:  Yan Zhong; Haiyi Wang; Yanguang Shen; Aitao Guo; Jia Wang; Suhai Kang; Lu Ma; Jingjing Pan; Huiyi Ye
Journal:  Eur Radiol       Date:  2017-06-19       Impact factor: 5.315

4.  Response by authors re: Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.

Authors:  V G Bird; P Kanagarajah; G Morillo; D J Caruso; R Ayyathurai; R Leveillee; M Jorda
Journal:  World J Urol       Date:  2011-05-05       Impact factor: 4.226

5.  Role of MRI in indeterminate renal mass: diagnostic accuracy and impact on clinical decision making.

Authors:  Taekmin Kwon; In Gab Jeong; Sangjun Yoo; JungBok Lee; Sungwoo Hong; Dalsan You; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Int Urol Nephrol       Date:  2015-02-14       Impact factor: 2.370

6.  Preoperative differentiation between benign and malignant renal masses smaller than 4 cm treated with partial nephrectomy.

Authors:  Masatomo Nishikawa; Hideaki Miyake; Kazuhiro Kitajima; Satoru Takahashi; Kazuro Sugimura; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2014-02-15       Impact factor: 3.402

7.  Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.

Authors:  Mark W Ball; Michael A Gorin; Sam B Bhayani; Craig G Rogers; Michael D Stifelman; Jihad H Kaouk; Homayoun Zargar; Susan Marshall; Jeffrey A Larson; Haider M Rahbar; Bruce J Trock; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-12-11       Impact factor: 3.498

8.  Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.

Authors:  F Cornelis; E Tricaud; A S Lasserre; F Petitpierre; J C Bernhard; Y Le Bras; M Yacoub; M Bouzgarrou; A Ravaud; N Grenier
Journal:  Eur Radiol       Date:  2014-02-21       Impact factor: 5.315

9.  Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada.

Authors:  Michael Organ; Michael Jewett; Joan Basiuk; Christopher Morash; Stephen Pautler; D Robert Siemens; Simon Tanguay; Martin Gleave; Darrell Drachenberg; Raymond Chow; Joseph Chin; Andrew Evans; Neil Fleshner; Brenda Gallie; Masoom Haider; John Kachura; Antonio Finelli; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2014 Jan-Feb       Impact factor: 1.862

10.  Role of open nephron sparing surgery in the era of minimal invasive surgery.

Authors:  Gaurav Gupta; Sameer Grover; Santosh Kumar; Nitin S Kekre
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.